CloudMD Software & Services Inc. (CVE:DOC – Get Rating)'s stock price reached a new 52-week low during trading on Thursday . The company traded as low as C$0.21 and last traded at C$0.21, with a volume of 111663 shares trading hands. The stock had previously closed at C$0.22.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the company. KeyCorp restated a "sector weight" rating on shares of CloudMD Software & Services in a research note on Friday, September 16th. Bloom Burton downgraded CloudMD Software & Services from a "buy" rating to a "hold" rating in a research note on Wednesday, August 24th. Finally, Canaccord Genuity Group dropped their price target on shares of CloudMD Software & Services from C$0.45 to C$0.40 in a research note on Wednesday, August 24th.
Get CloudMD Software & Services alerts:CloudMD Software & Services Trading Down 2.4 %
The company has a 50 day simple moving average of C$0.30 and a 200 day simple moving average of C$0.42. The company has a market capitalization of C$60.18 million and a PE ratio of -1.56. The company has a debt-to-equity ratio of 16.42, a quick ratio of 1.46 and a current ratio of 1.67.
CloudMD Software & Services Company Profile
(Get Rating)CloudMD Software & Services Inc operates as a healthcare technology company in North America. The company operates through three segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions. It offers enterprise health solutions, including mental health support, healthcare navigation, rehabilitation and assessments, education, and absence management and occupational health.
Recommended Stories
- Should Investors Raise a Glass to Boston Beer Company?
- MarketBeat: Week in Review 10/17-10/21
- The Institutions Spin Whirlpool Into Bargain Basement Territory
- American Express Beats Earnings & Revenue Views, Raises Guidance
- Snap Stock Falls As User Growth Slows To Single-Digits
Receive News & Ratings for CloudMD Software & Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CloudMD Software & Services and related companies with MarketBeat.com's FREE daily email newsletter.